Increased Red Blood Cell Distribution Width in the First Year after Diagnosis Predicts Worsening of Systemic Sclerosis-Associated Interstitial Lung Disease at 5 Years: A Pilot Study

被引:5
作者
Ebata, Satoshi [1 ]
Yoshizaki, Ayumi [1 ]
Fukasawa, Takemichi [1 ]
Yoshizaki-Ogawa, Asako [1 ]
Asano, Yoshihide [1 ]
Kashiwabara, Kosuke [2 ]
Oba, Koji [3 ,4 ]
Sato, Shinichi [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Dept Dermatol, Tokyo 1138655, Japan
[2] Tokyo Univ Hosp, Clin Res Support Ctr, Tokyo 1138655, Japan
[3] Univ Tokyo, Sch Publ Hlth, Grad Sch Med, Dept Biostat, Tokyo 1130033, Japan
[4] Univ Tokyo, Interfac Initiat Informat Studies, Tokyo 1130033, Japan
关键词
forced vital capacity; peripheral blood marker; red blood cell distribution width; systemic sclerosis; systemic sclerosis-associated interstitial lung disease; CARDIOVASCULAR RISK; CLINICAL-TRIALS; DOUBLE-BLIND; SCLERODERMA; STANDARDIZATION; CLASSIFICATION; MORTALITY; SUBSETS;
D O I
10.3390/diagnostics11122274
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The course of systemic sclerosis-associated interstitial lung disease (SSc-ILD) varies among individuals. Red blood cell distribution width (RDW) has been reported to be a predictor of idiopathic pulmonary fibrosis. However, there are no studies on the relationship between RDW and SSc-ILD. We conducted a retrospective study of 28 patients who were diagnosed with SSc-ILD on their first visit to our hospital and were followed-up for 5 years. The correlation between the changes in RDW, KL-6, and SP-D (Delta RDW, Delta KL-6, Delta SP-D) and the changes in percent-predicted forced lung volume and % carbon monoxide diffusion (Delta%FVC, Delta%DLco) was investigated. Delta RDW at 1 year after diagnosis was significantly inversely correlated with Delta%FVC at 5 years after diagnosis (r = -0.51, p < 0.001) and Delta%DLco at 5 years after diagnosis (r = -0.47, p < 0.001), whereas Delta KL-6 and Delta SP-D at 1 year were not correlated with Delta%FVC or Delta%DLco at 5 years. In the group of SSc-ILD patients with RDW increase in the first year after diagnosis, %FVC and %DLco were significantly lower than baseline at 3-, 4-, and 5-year assessments. In the group of patients without RDW increase in the first year, %FVC and %DLco did not decrease during the follow-up period. In conclusion, the changes in RDW in the first year after diagnosis may be useful surrogate markers to predict the long-term course of SSc-ILD.
引用
收藏
页数:8
相关论文
共 29 条
[1]   Systemic sclerosis [J].
Allanore, Yannick ;
Simms, Robert ;
Distler, Oliver ;
Trojanowska, Maria ;
Pope, Janet ;
Denton, Christopher P. ;
Varga, John .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[2]   Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature [J].
Bonhomme, Olivier ;
Andre, Beatrice ;
Gester, Fanny ;
de Seny, Dominique ;
Moermans, Catherine ;
Struman, Ingrid ;
Louis, Renaud ;
Malaise, Michel ;
Guiot, Julien .
RHEUMATOLOGY, 2019, 58 (09) :1534-1546
[3]   Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome [J].
Bouros, D ;
Wells, AU ;
Nicholson, AG ;
Colby, TV ;
Polychronopoulos, V ;
Pantelidis, P ;
Haslam, PL ;
Vassilakis, DA ;
Black, CM ;
du Bois, RM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (12) :1581-1586
[4]   Systemic sclerosis [J].
Denton, Christopher P. ;
Khanna, Dinesh .
LANCET, 2017, 390 (10103) :1685-1699
[5]   Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease [J].
Distler, Oliver ;
Highland, Kristin B. ;
Gahlemann, Martina ;
Azuma, Arata ;
Fischer, Aryeh ;
Mayes, Maureen D. ;
Raghu, Ganesh ;
Sauter, Wiebke ;
Girard, Mannaig ;
Alves, Margarida ;
Clerisme-Beaty, Emmanuelle ;
Stowasser, Susanne ;
Tetzlaff, Kay ;
Kuwana, Masataka ;
Maher, Toby M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (26) :2518-2528
[6]   Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial [J].
Ebata, Satoshi ;
Yoshizaki, Ayumi ;
Oba, Koji ;
Kashiwabara, Kosuke ;
Ueda, Keiko ;
Uemura, Yukari ;
Watadani, Takeyuki ;
Fukasawa, Takemichi ;
Miura, Shunsuke ;
Yoshizaki-Ogawa, Asako ;
Asano, Yoshihide ;
Okiyama, Naoko ;
Kodera, Masanari ;
Hasegawa, Minoru ;
Sato, Shinichi .
LANCET RHEUMATOLOGY, 2021, 3 (07) :E489-E497
[7]   Clinical usefulness of measuring red blood cell distribution width in patients with systemic sclerosis [J].
Farkas, Nelli ;
Szabo, Andrea ;
Lorand, Veronika ;
Sarlos, Donat Peter ;
Minier, Tuende ;
Prohaszka, Zoltan ;
Czirjak, Laszlo ;
Varju, Cecilia .
RHEUMATOLOGY, 2014, 53 (08) :1439-1445
[8]   Interstitial lung disease in systemic sclerosis: current and future treatment [J].
Giacomelli, Roberto ;
Liakouli, Vasiliki ;
Berardicurti, Onorina ;
Ruscitti, Piero ;
Di Benedetto, Paola ;
Carubbi, Francesco ;
Guggino, Giuliana ;
Di Bartolomeo, Salvatore ;
Ciccia, Francesco ;
Triolo, Giovanni ;
Cipriani, Paola .
RHEUMATOLOGY INTERNATIONAL, 2017, 37 (06) :853-863
[9]   Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis [J].
Goh, Nicole S. ;
Hoyles, Rachel K. ;
Denton, Christopher P. ;
Hansell, David M. ;
Renzoni, Elisabetta A. ;
Maher, Toby M. ;
Nicholson, Andrew G. ;
Wells, Athol U. .
ARTHRITIS & RHEUMATOLOGY, 2017, 69 (08) :1670-1678
[10]   Red cell distribution width: a measure of cardiovascular risk in rheumatoid arthritis patients? [J].
Hassan, Sobia ;
Antonelli, Maria ;
Ballou, Stanley .
CLINICAL RHEUMATOLOGY, 2015, 34 (06) :1053-1057